Watchlist Price Alert

Talaris Therapeutics Inc. (TALS)

NASDAQ: TALS · Real-Time Price · USD

2.72

-0.02 (-0.73%)

At close: Oct 19, 2023, 8:00 PM

Talaris Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	67.08M	18.35M	24.22M	13.67M	18.47M	25.52M	22.79M	18.61M	27.31M	36.3M	9.89M	17.59M
Short-Term Investments	79.94M	133.9M	141.59M	167.61M	175.4M	181.59M	202.74M	225.36M	227.42M	229.92M	130.21M	131.9M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	14K	1.86M	111K	111K	111K	111K	111K	104K	104K	89K	14K	14K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	477K	374K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.16M	813K
Other Current Assets	4.02M	3.96M	3.05M	4.33M	4.26M	4.92M	2.89M	2.54M	3.49M	4.25M	2.7M	76K
Total Current Assets	151.05M	156.21M	168.86M	185.61M	198.13M	212.04M	228.42M	246.51M	258.23M	270.47M	142.8M	150.75M
Property-Plant & Equipment	n/a	1.05M	3.64M	7.99M	8.31M	8.77M	8.72M	4.8M	2.99M	2.25M	2.08M	2.01M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	14K	2.91M	3.75M	8.1M	8.42M	8.88M	8.83M	4.91M	3.1M	2.34M	2.1M	2.03M
Total Assets	151.06M	159.12M	172.61M	193.72M	206.54M	220.92M	237.25M	251.42M	261.32M	272.81M	144.9M	152.78M
Account Payables	136K	2.93M	3.38M	3.89M	2.13M	2.08M	3.48M	2.56M	1.18M	1.26M	769K	767K
Deferred Revenue	n/a	6.35M	n/a	n/a	n/a	n/a	3.1M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	634K	601K	751K	910K	905K	835K	740K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	7.33M	6.6M	6.04M	6.67M	6.13M	4.42M	3.84M	5.43M	3.8M	3.4M	2.81M	2.64M
Total Current Liabilities	8.11M	10.13M	10.18M	11.46M	9.17M	7.33M	8.06M	7.99M	4.98M	4.66M	3.58M	3.4M
Long-Term Debt	n/a	425K	521K	1.97M	2.2M	2.43M	2.66M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	82K	130K	176K	224K	310K	413K	492K	626K	694K	800K	187.78M	1.37M
Total Long-Term Liabilities	82K	555K	697K	2.2M	2.51M	2.84M	3.15M	626K	694K	800K	187.78M	1.37M
Total Liabilities	8.19M	10.69M	10.88M	13.66M	11.68M	10.17M	11.22M	8.61M	5.68M	5.46M	191.37M	4.77M
Total Debt	634K	1.03M	1.27M	2.88M	3.1M	3.27M	3.4M	n/a	n/a	n/a	n/a	n/a
Common Stock	n/a	4K	4K	4K	4K	4K	4K	4K	4K	4K	1K	3K
Retained Earnings	-208.99M	-201.98M	-187.24M	-164.74M	-146.21M	-127.2M	-109.11M	-90.85M	-76.61M	-63.66M	-52.31M	-43.01M
Comprehensive Income	-115K	-214K	-299K	-721K	-1.22M	-1.14M	-926K	-78K	29K	34K	9K	-13K
Shareholders Equity	142.87M	148.43M	161.73M	180.06M	194.87M	210.74M	226.03M	242.81M	255.65M	267.35M	-46.47M	148M
Total Investments	79.94M	133.9M	141.59M	167.61M	175.4M	181.59M	202.74M	225.36M	227.42M	229.92M	130.21M	131.9M